Dusseldorf - Delayed Quote EUR

Haemonetics Corp (HAZ.DU)

Compare
77.50 -0.50 (-0.64%)
At close: June 17 at 7:31 PM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
1,309,055.00
1,309,055.00
1,168,660.00
993,196.00
870,463.00
Cost of Revenue
617,507.00
617,507.00
553,563.00
487,694.00
472,625.00
Gross Profit
691,548.00
691,548.00
615,097.00
505,502.00
397,838.00
Operating Expense
518,246.00
518,246.00
459,446.00
434,355.00
340,903.00
Operating Income
173,302.00
173,302.00
155,651.00
71,147.00
56,935.00
Net Non Operating Interest Income Expense
-13,018.00
-13,018.00
-14,630.00
-17,121.00
-16,834.00
Other Income Expense
-8,419.00
-8,419.00
382.00
9,603.00
32,812.00
Pretax Income
151,865.00
151,865.00
141,403.00
63,629.00
72,913.00
Tax Provision
34,307.00
34,307.00
26,002.00
20,254.00
-6,556.00
Net Income Common Stockholders
117,558.00
117,558.00
115,401.00
43,375.00
79,469.00
Diluted NI Available to Com Stockholders
117,558.00
117,558.00
115,401.00
43,375.00
79,469.00
Basic EPS
2.50
2.32
2.27
0.85
1.57
Diluted EPS
2.46
2.29
2.24
0.84
1.55
Basic Average Shares
50,620.25
50,706.00
50,783.00
51,047.00
50,688.00
Diluted Average Shares
51,350.25
51,397.00
51,420.00
51,353.00
51,292.00
Total Operating Income as Reported
164,883.00
164,883.00
156,033.00
80,750.00
89,747.00
Total Expenses
1,135,753.00
1,135,753.00
1,013,009.00
922,049.00
813,528.00
Net Income from Continuing & Discontinued Operation
117,558.00
117,558.00
115,401.00
43,375.00
79,469.00
Normalized Income
124,074.31
124,074.31
115,089.29
34,175.33
55,516.24
Interest Expense
13,018.00
13,018.00
14,630.00
17,121.00
16,834.00
Net Interest Income
-13,018.00
-13,018.00
-14,630.00
-17,121.00
-16,834.00
EBIT
164,883.00
164,883.00
156,033.00
80,750.00
89,747.00
EBITDA
262,098.00
262,098.00
249,340.00
178,497.00
174,034.00
Reconciled Cost of Revenue
552,323.00
552,323.00
492,896.00
437,361.00
421,168.00
Reconciled Depreciation
97,215.00
97,215.00
93,307.00
97,747.00
84,287.00
Net Income from Continuing Operation Net Minority Interest
117,558.00
117,558.00
115,401.00
43,375.00
79,469.00
Total Unusual Items Excluding Goodwill
-8,419.00
-8,419.00
382.00
9,603.00
32,812.00
Total Unusual Items
-8,419.00
-8,419.00
382.00
9,603.00
32,812.00
Normalized EBITDA
270,517.00
270,517.00
248,958.00
168,894.00
141,222.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-1,902.69
-1,902.69
70.29
403.33
8,859.24
3/31/2021 - 4/11/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

JX7.DU Embecta Corp
11.40
-5.79%
 
HBI.DU Harvard Bioscience Inc
2.6200
-0.76%
 
EP3.DU OraSure Technologies Inc
3.8400
-4.00%
 
CBH.DU Coloplast A/S
11.20
0.00%
 
ADDLF AddLife AB (publ)
7.94
-77.50%
 
AFXA.DU Carl Zeiss Meditec AG
66.50
-19.88%
 
CBHD.DE Coloplast A/S
113.35
+0.09%
 
CZMWY Carl Zeiss Meditec AG
72.40
-19.43%
 
EKTA-B.ST Elekta AB (publ)
66.00
+0.76%
 
TECN.SW Tecan Group AG
306.00
-5.44%